Genmab A/S ADR (NQ: GMAB )
28.15
+0.27
(+0.97%)
Streaming Delayed Price
Updated: 11:06 AM EDT, Jul 25, 2024
Add to My Watchlist
All News about Genmab A/S ADR![]() ![]() ![]() ![]()
HC Wainwright Is Bullish On This Multiple Myeloma Focused Stock
August 22, 2022
Via Benzinga
![]() ![]()
Genmab, BioNTech Join Forces For Cancer Immunotherapy Candidates
August 05, 2022
Via Benzinga
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]()
Seagen, Zai Lab Ink Regional Strategic Licensing Agreement For Cervical Cancer Treatment
September 27, 2022
Via Benzinga
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]()
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|
Penticton Herald
Phone number: 250-492-4002
E-mail: csr@ok.bc.ca
Address: 186 Nanaimo Ave. W.
Penticton, BC V2A 1N4
© Copyright 2015, Penticton Herald, Penticton, BC. Powered by BLOX Content Management System from TownNews.com.